Interlink Electronics, Inc.

NASHVILLE, Tenn., Oct. 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-driven biopharmaceutical company advancing new therapies that address significant unmet medical needs, confirmed that it will provide an update on its ifetroban product candidate in development as a potential treatment for the cardiomyopathy associated with Duchenne muscular dystrophy ("DMD").

Interlink Electronics NASDAQ: LINK is pursuing a roll-up strategy in sensors, printed electronics and engineered solutions, with Chairman, President and CEO Steve Bronson outlining plans to expand through acquisitions, cross-selling and internal integration.

Three AI models gave Chainlink price targets for 2028, and while two landed above $25, the reasoning behind the outlier forecast may be the most convincing of all.

Archax just tapped Chainlink to power its FCA-regulated tokenized Treasury product, but the deal left LINK traders in the red. Before you rebalance your crypto portfolio, there are some critical details buried in this partnership that could change how you see both LINK and XRP.

A new tokenization partnership in Japan gave Chainlink bulls reason to cheer, yet LINK fell anyway. Whether the token can claw back to $15 depends on forces that have nothing to do with the deal.

Three out of four crypto holders want their bank to manage their digital assets, yet most Americans still juggle separate apps, logins, and tax forms to do it. A handful of brokerages just changed that equation, but the fees, withdrawal limits, and insurance gaps may surprise you.

The Chainlink Reserve spends real revenue buying LINK off the market every day, yet the token keeps sliding lower. Something is overpowering the buying pressure, and it raises a bigger question about how much a built-in buyer can actually do.

ChatGPT gave four beaten-down cryptocurrencies wildly different odds of doubling, and the winner may surprise anyone who assumed Ethereum still leads the pack.